
News|Articles|December 7, 2007
Aetna launches Healthy Actions Rx-Savings program
Healthy Actions Rx-Savings program debuts from Aetna
Advertisement
Healthy Actions Rx-Savings, an incentive program under which co-pays for individuals enrolled in self-funded benefit plans who have high-risk clinical profiles and are taking medication for chronic health conditionsincluding asthma, diabetes, high cholesterol, high blood pressure, and heart diseaseare paid in whole or in part by their employer. The program is designed to encourage member compliance with medications shown to be essential, according to the evidence base, to the effective management of these conditions for high-risk members.
Advertisement
Related to this article

This episode breaks down how PBMs conduct inventory audits, the sourcing and timing issues that trigger recoupments, and how pharmacies can prepare and push back.

In part 2 of our discussion with Kimberly Kue-Tsemo, PharmD, she addresses the emergence of technology and the nuances behind its actual capabilities.

In part 2, Allison Schneider, MPH, discusses PBM and 340B reform that could compound pharmacies’ burden amid ongoing Medicare drug price negotiations.

Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.

Type 1 and type 2 diabetes reports emphasize areas where pharmacists can act now, including CGM, cardio-kidney therapies, and equitable patient access.

Kimberly Kue-Tsemo, PharmD, explores the current state of US pharmacy deserts amid ongoing reform, evolution in practice, and more.

Alyssa Eisenberg, PharmD, discusses key industry challenges and developments as community pharmacists continue to impact patient outcomes across the US.
Advertisement
Advertisement
Trending on Drug Topics
1
Updated Diabetes Consensus Shifts Focus from Glucose Control to Whole-Person Care
2
No Added Adverse Event Risk in Pfizer-BioNTech COVID-19 Vaccine
3
What the CLARITY Study Means for Counseling on Long-Acting HIV PrEP
4
Q&A: Overlapping PBM, 340B Reform Create Uncertainty for Pharmacies
5

